secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001104659-25-014748
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma raises ~$20M in Dec 31 offering; believes it now meets Nasdaq equity minimum
--------------------------------------------------------------------------------

- Closed Dec 31, 2024 unit offering; gross proceeds ~$20M, up to $52.6M more on warrant exercise.
- Company now believes stockholders' equity is at least $2.5M, addressing Nasdaq Rule 5550(b)(1).
- Awaiting Nasdaq confirmation; no assurance that compliance will be formally determined.
- Hearing panel had granted exception until Feb 18, 2025; filing updates status.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925014748/0001104659-25-014748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925014748/tm256499d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-014748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer